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Blood-borne naive lymphocytes continuously 
enter secondary lymphoid organs (SLOs), such 
as peripheral lymph nodes (PLNs) and spleen, 
where they screen APCs in search of their cog-
nate antigen. In absence of infl  ammation, lym-
phocytes leave PLNs after an average dwell 
time of 12–24 h to enter lymphatic vessels lo-
cated in the lymph node medulla (1, 2). Eff  erent 
lymph vessels carry lymphocytes back into the 
blood circulation from where they reinitiate 
their recirculation pathway. Their long life 
span and constant migration through SLOs 
make lymphocytes one of the most motile 
mammalian cell types (1, 2). Together with ad-
hesion receptor molecules, two subfamilies of 
lymphocyte-expressed G protein–coupled re-
ceptors (GPCRs) are known to guide lympho-
cyte traffi   cking: chemokine receptors (CKR), 
including CCR7, CXCR4, and CXCR5, and 
the sphingosine-1-phosphate (S1P) receptor 1, 
S1P1 (1, 2).
SLO-expressed homeostatic chemokines, 
such as the CCR7 ligands CCL19 and CCL21, 
the CXCR5 ligand CXCL13, and the CXCR4 
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Recent observations using multiphoton intravital microscopy (MP-IVM) have uncovered an 
unexpectedly high lymphocyte motility within peripheral lymph nodes (PLNs). Lymphocyte-
expressed intracellular signaling molecules governing interstitial movement remain largely 
unknown. Here, we used MP-IVM of murine PLNs to examine interstitial motility of lym-
phocytes lacking the Rac guanine exchange factor DOCK2 and phosphoinositide-3-kinase 
(PI3K)𝗄, signaling molecules that act downstream of G protein–coupled receptors, including 
chemokine receptors (CKRs). T and B cells lacking DOCK2 alone or DOCK2 and PI3K𝗄 
displayed markedly reduced motility inside T cell area and B cell follicle, respectively. Lack 
of PI3K𝗄 alone had no effect on migration velocity but resulted in increased turning angles 
of T cells. As lymphocyte egress from PLNs requires the sphingosine-1-phosphate (S1P) 
receptor 1, a G𝗂i protein–coupled receptor similar to CKR, we further analyzed whether 
DOCK2 and PI3K𝗄 contributed to S1P-triggered signaling events. S1P-induced cell migra-
tion was signifi  cantly reduced in T and B cells lacking DOCK2, whereas T cell–expressed 
PI3K𝗄 contributed to F-actin polymerization and protein kinase B phosphorylation but not 
migration. These fi  ndings correlated with delayed lymphocyte egress from PLNs in the 
absence of DOCK2 but not PI3K𝗄, and a markedly reduced cell motility of DOCK2-defi  cient 
T cells in close proximity to efferent lymphatic vessels. In summary, our data support a 
central role for DOCK2, and to a lesser extent T cell–expressed PI3K𝗄, for signal transduc-
tion during interstitial lymphocyte migration and S1P-mediated egress.
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ligand CXCL12, fulfi   ll two functions during lymphocyte 
traffi   cking. First, they are presented on high endothelial ven-
ules (HEVs) where they promote fi  rm arrest of blood-borne 
lymphocytes (1–5). Second, chemokines organize lymphoid 
tissue by creating specifi  c microenvironments. Transmigrated 
CCR7high T cells move to the PLN paracortex correlating 
with CCL21 and CCL19 expressed at high concentrations 
in this area, whereas CXCR5-expressing B cells accumulate 
in follicles where high levels of CXCL13 are present (1–3). 
Accordingly, mice lacking homeostatic chemokines or their 
receptors show disturbed SLO architecture, with poorly de-
veloped T and B cell areas (6–9).
The recent establishment of multiphoton intravital 
microscopy (MP-IVM) has allowed investigators to directly 
visualize the dynamics of lymphocyte motility within their 
microenvironments of primary and secondary lymphoid tis-
sues (10–15). Somewhat unexpectedly, most nonactivated 
naive lymphocytes display a highly motile behavior that has 
been described as random walk (11–15). In fact, lymphocytes 
appear to use stromal cell networks as guidance cues for 
their migration paths (16). Continuous lymphocyte motility 
may have evolved to increase “antigen scanning effi   ciency” 
and, as a consequence, the likelihood of productive APC–
  lymphocyte encounters. It is currently unclear whether che-
mokines or additional tissue-derived factors are responsible 
for lymphocyte motility observed in lymphoid tissue. Inter-
estingly, in two-dimensional in vitro assay systems, chemo-
kines can increase random motility in apparent absence of 
gradients (17, 18), and studies in B cells lacking the Gαi2 sub-
unit and regulator of G protein signaling (RGS)1 have un-
covered a central role for GPCR signaling during interstitial 
migration (19).
In the absence of infl  ammation, lymphocytes exit PLNs 
through lymphatic sinuses located in the medulla of PLNs 
(1, 2). S1P receptor 1 (S1P1) is a Gαi-coupled receptor, which, 
together with its ligand, has been implicated in the regulation 
of lymphocyte egress (1, 20). First evidence for a role of S1P 
came from pharmacological studies using an S1P analogue, 
FTY720, which in its phosphorylated form (FTY720-P) acts 
as a strong agonist on four out of fi  ve known S1P receptors, 
including S1P1 (20, 21). FTY720 administration leads to a 
severe block of lymphocyte egress from PLNs, with con-
comitant blood lymphopenia (21, 22). In lymphocytes, 
FTY720 induces S1P1 internalization and a long-lasting state 
of nonresponsiveness to S1P (23, 24). Likewise, S1P1-defi  cient 
thymocytes are unable to egress from the thymus, and 
when adoptively transferred into recipient mice, mature 
S1P1-defi  cient thymocytes accumulate in PLNs but are un-
able to exit these or any other SLO (24, 25). Despite its im-
portance, very little is known about S1P-induced intracellular 
signaling pathways in lymphocytes.
DOCK2 is a hematopoietic cell–specifi  c member of the 
CDM (CED-5 in Caenorhabditis elegans, DOCK180 in man, 
and myoblast city in Drosophila melanogaster) family of pro-
teins, which functions as a guanine exchange factor for the 
small GTPase Rac (26–28). Rac is a key regulator of cell 
motility by controlling F-actin polymerization and lamelli-
podia formation (29). In the absence of DOCK2, chemokine-
induced F-actin polymerization, directed in vitro migration 
to chemokine gradients, and short-term homing are strongly 
impaired in T and B cells, despite similar CKR surface expres-
sion levels (30, 31). A DOCK2-independent, phosphoinositide-
3-kinase (PI3K)-dependent residual chemotactic response 
nonetheless exists in lymphocytes, which during in vitro mi-
gration requires PI3Kγ in T cells, whereas the PI3Kδ isoform 
appears to be predominant in B cells (31, 32). Accordingly, 
PI3Kγ-defi  cient T but not B cells show a mild reduction in 
their homing effi   ciency to SLOs. T cells lacking both DOCK2 
and PI3Kγ show a virtually abolished migration to chemo-
kines in vitro and have a further reduced homing capacity 
toward SLOs (31).
Although the roles of DOCK2 and PI3Kγ during che-
mokine-mediated lymphocyte migration in vitro and lym-
phocyte homing from blood to SLOs in vivo are well 
described, it was unclear whether and how these molecules 
would aff  ect velocity and directionality of interstitially mi-
grating lymphocytes. We have therefore investigated the 
role of both molecules by directly comparing the migratory 
behavior of adoptively transferred control, DOCK2−/−, 
PI3Kγ−/−, or DOCK2−/− × PI3Kγ−/− T and B cells inside 
the PLNs of anesthetized mice using MP-IVM, as described 
previously (33). Our fi  ndings show that cells lacking DOCK2 
display a strongly reduced interstitial motility with decreased 
translocation speed and increased turning angles, resulting in 
a low motility coeffi   cient. In contrast, T cell directionality 
was only mildly aff  ected in the absence of PI3Kγ. Finally, 
we also address the function of DOCK2 and PI3Kγ in S1P-
stimulated T and B cells in vitro and during lymph node egress 
in vivo, using egress assays and MP-IVM of PLN medulla.
RESULTS
Intranodal motility of T cells in the absence of DOCK2 
and PI3K𝗄
T cell migration along chemokine gradients in vitro, as well as 
homing to SLOs in vivo, requires DOCK2-induced Rac activa-
tion (30), with a residual PI3Kγ-dependent contribution (31, 32). 
To investigate how the lack of DOCK2 and/or PI3Kγ infl  u-
enced interstitial motility of lymphocytes that had successfully 
entered lymphoid tissue, we adoptively transferred purifi  ed 
control T cells together with DOCK2−/−, PI3Kγ−/−, or 
DOCK2−/− × PI3Kγ−/− T cells diff  erentially labeled with 
CFSE or CMTMR. To compensate for the reduced accumula-
tion of DOCK2-defi  cient T cells in PLNs (30, 31), two to four 
times more of these cells were injected compared with control 
cells. After 15–22 h, direct imaging of the T cell area of popliteal 
lymph nodes was performed using MP-IVM (33), and the in situ 
interstitial migratory behavior of transferred control and gene-
defi   cient lymphocytes was compared during 30-min periods 
within the same fi  eld of view. Flow cytometry analysis of trans-
ferred control and DOCK2-defi  cient lymphocytes recovered 
from PLNs revealed that both populations consisted of 70–90% 
L-selectinhigh CD44low LFA-1intermediate CD45RBhigh cells, JEM VOL. 204, March 19, 2007  499
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  indicative of bona fi  de naive lymphocytes. The remaining cells 
were L-selectinhigh CD44high LFA-1intermediate CD45RBhigh cen-
tral memory–like T cells, which were more frequent in the 
absence of DOCK2 (12 ± 4% vs. 29 ± 2% control and 
DOCK2−/− T cells, respectively; Fig. S1, available at http://
www.jem.org/cgi/content/full/jem.20061780/DC1). We did 
not observe a bimodal migratory behavior within control or 
DOCK2-  defi  cient lymphocyte populations in our experi-
ments (see   below), suggesting that naive and central memory–
like populations have comparable motility.
As reported (11, 33), control T cells vigorously migrated 
in what appeared a random walk pattern, frequently entering 
and leaving the fi  eld of view during the observation period. 
In contrast, most DOCK2−/− T cells oscillated around the 
initial tracking spot, unable to initiate steady movement in 
any direction (Fig. 1 A). Of note, most DOCK2−/− T cells 
still underwent continuous shape changes and emitted cell 
projections that appeared to correspond to the formation of a 
transient leading edge (Videos S1 and S2, available at http://
www.jem.org/cgi/content/full/jem.20061780/DC1). Al-
ternatively, the apparent residual shape changes of DOCK2-
defi   cient cells could have resulted, at least in part, from 
collisions with highly motile endogenous cells. Although 
control T cells traveled with a median instantaneous three-
dimensional velocity of 12.6 ± 0.7 μm/min (mean ± SD), 
DOCK2−/− T cells moved with 7.0 ± 0.1 μm/min (Fig. 1 B). 
As the instantaneous three-dimensional velocity is calcu-
lated on the basis of the frame to frame changes of single cell 
centroid positions, small displacements or shape changes are 
also included. This could account for the fact that DOCK2 
defi  ciency induced a less remarkable reduction in the mean 
instantaneous three-dimensional velocity than predicted 
from the three-dimensional trajectories of DOCK2−/− T cells 
(Fig. 1 A). We occasionally observed DOCK2−/− T cells 
migrating comparably to control T cells in terms of displace-
ment and speed (Videos S1 and S2), indicating that DOCK2-
independent pathways controlling cell migration are present 
in rare T cells.
The erratic oscillations of DOCK2−/− T cells around the 
initial tracking spot are refl  ected by the turning angle fre-
quency distribution, indicating decreased directionality (Fig. 
1 C). To account for both instantaneous three-dimensional 
Figure 1.  Paracortical T cell migration in the absence of DOCK2 
and PI3K𝗄. Fluorescently labeled control T cells and DOCK2−/−, PI3Kγ−/−, 
or DOCK2−/− × PI3Kγ−/− T cells were adoptively transferred into wild-
type recipients, and their migratory behavior inside popliteal lymph nodes 
was analyzed using MP-IVM. The grid length of each square corresponds 
to 20.8 μm. (A) Representative three-dimensional tracks of control T cells 
(+/+; left column) and DOCK2−/−, PI3Kγ−/−, or DOCK2−/− × PI3Kγ−/− 
T cells (−/−; right column) over 30-min periods. Each colored line repre-
sents a single T cell track. (B) Velocity profi  les of control T cells (green 
bars) and DOCK2−/−, PI3Kγ−/−, or DOCK2−/− × PI3Kγ−/− T cells (red bars). 
Histograms show the relative frequency distribution of different popu-
lations compared with control T cells. (C) Turning angles of control T 
cells (+/+; top green panel) and DOCK2−/−, PI3Kγ−/−, or DOCK2−/− × 
PI3Kγ−/− T cells (−/−; bottom red panel). The wider angle distribution 
of DOCK2-defi  cient T cells is indicative of less directed cell movement. 
(D) Motility coeffi  cients of T cells in the presence or absence of DOCK2 
and/or PI3Kγ. Each dot represents the combined motility coeffi  cient 
of one experiment. Filled dots, control T cells; empty dots, genetically 
defi  cient T cells. The bars indicate mean values. The statistical analysis is 
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velocity and turning angle distribution, we determined the 
motility coeffi   cient for control and DOCK2−/− T cells as a 
measure of area scanning effi   ciency per time unit (Fig. 1 D) 
(12). In the absence of DOCK2, the motility coeffi   cient de-
creased to 4.8 ± 2.8 μm2/min, refl  ecting the scarce displace-
ments of DOCK2−/− T cells. Control T cells, on the other 
hand, had an  15-fold higher motility coeffi   cient of 72.9 ± 
3.7 μm2/min, in line with previous reports (13, 33). All MP-
IVM motility parameters are summarized in Table I.
To analyze the role of PI3Kγ during lymphocyte intra-
nodal motility, we performed MP-IVM experiments com-
paring purifi  ed control and PI3Kγ−/− T cells. In six 30-min 
videos analyzed, PI3Kγ−/− T cells showed no signifi  cant 
reduction of the median instantaneous three-dimensional 
velocity (PI3Kγ+/+ T cells, 11.5 ± 0.8 μm/min; PI3Kγ−/− 
T cells, 11.0 ± 1.3 μm/min; Fig. 1 B and Video S3, 
which is available at http://www.jem.org/cgi/content/full/
jem.20061780/DC1). However, a more thorough compari-
son of turning angles uncovered a slight shift toward wider 
turning angles in the absence of PI3Kγ. This observation in-
dicates that PI3Kγ−/− T cells undergo more abrupt direc-
tional changes during interstitial migration compared with 
control cells (Fig. 1 C), which is refl  ected in the minor but 
signifi  cant reduction of the PI3Kγ−/− T cell motility coeffi   -
cient (59.2 ± 7.3 compared with 70.6 ± 8.5 μm2/min of 
control cells; Fig. 1 D and Table I).
In homing experiments, both DOCK2 and, to a minor 
extent, PI3Kγ contribute to effi   cient T cell accumulation in 
PLNs (31). We set out to analyze the combined eff  ect of 
these signaling molecules on lymphocyte motility inside 
PLNs. Adoptively transferred DOCK2−/− × PI3Kγ−/− T 
cells behaved comparably to T cells lacking only DOCK2, 
remaining essentially stationary during the observation period 
(Table I and Videos S4 and S5, which are available at http://
www.jem.org/cgi/content/full/jem.20061780/DC1). Col-
lectively, these observations reveal a central role for DOCK2, 
and to a lesser extent PI3Kγ, during signal transduction of 
tissue-derived promigratory signals causing effi   cient intersti-
tial T cell motility.
DOCK2 but not PI3K𝗄 controls B cell motility inside 
the follicles
B cell migration to chemokines in vitro requires DOCK2 and 
a PI3K isoform diff  erent from PI3Kγ (31, 32). We therefore 
investigated the infl  uence of DOCK2 on B cell random motil-
ity using MP-IVM. In the absence of DOCK2, B cell homing 
to PLNs is further diminished compared with DOCK2−/− 
T cells due to the B cell–specifi  c requirement for DOCK2 
during effi   cient integrin activation (31). However, when trans-
ferring three to fi  ve times more purifi  ed DOCK2−/− B cells 
compared with control B cells, we were able to observe a suf-
fi  cient number of gene-defi  cient cells for a meaningful analysis 
of their migratory behavior (Table I). As for T cells, transferred 
control and DOCK2-defi  cient B cells were >90% L-selectinhigh 
(not depicted).
15–22 h after transfer, most transferred B cells, regardless 
of DOCK2 expression, were detected in external areas of 
the lymph nodes in close proximity to the subcapsular sinus, 
where B cell follicles are located. Compared with T cells, 
control B cells displayed a lower median instantaneous 
three-dimensional velocity (7.9 ± 0.8 μm/min). An exami-
nation of frequency histograms of three-dimensional veloc-
ities revealed a reduction in DOCK2−/− B cell translocation 
speed to a mean velocity of 5.2 ± 0.9 μm/min (Fig. 2 B and 
Table I). Importantly, individual three-dimensional cell 
tracks refl   ect the severely compromised displacement of 
DOCK2−/− B cells during the observation period, although 
some cells were observed emitting cell membrane projec-
tions, similar to DOCK2−/− T cells (Fig. 2 A). The contin-
uous changes in direction and oscillations around the initial 
tracking spot resulted in increased turning angles and a 
strongly reduced motility coeffi   cient (1.7 ± 0.9 μm2/min 
for DOCK2−/− B cells vs. 23.7 ± 4.1 μm2/min for control 
cells; Fig. 2, C and D).
Table I.  Motility parameters of control and DOCK2- and/or PI3Kγ-defi  cient T and B cells
Control DOCK2−/− Control PI3K𝗄−/− Control DOCK2−/− × PI3K𝗄−/−
T cells
Number of experiments 4 6 4
Number of tracks 842 370 198 299 196 86
3D velocity (μm min−1) 12.6 ± 0.7 7.0 ± 0.1a 11.5 ± 0.8 11.0 ± 1.3 12.2 ± 1.4 6.2 ± 0.5a
Turning angle distribution narrow broad narrow slightly broader narrow broad
Motility coeffi  cient (μm2 min−1) 72.9 ± 3.7 4.8 ± 2.8a 70.6 ± 8.5 59.2 ± 7.3a 71.3 ± 4.9 3.2 ± 1.9a
B cells
Number of experiments 4 6 4
Number of tracks 133 35 134 83 243 59
3D velocity (μm min−1) 7.9 ± 0.8 5.2 ± 0.9a 8.1 ± 0.3 7.5 ± 0.7 8.3 ± 0.2 5.9 ± 0.6a
Turning angle distribution narrow broad narrow narrow narrow broad
Motility coeffi  cient (μm2 min−1) 23.7 ± 4.1 1.7 ± 0.9a 21.9 ± 5.2 24.3 ± 3.2 23.6 ± 5.4 2.5 ± 1.0a
aSignifi  cantly lower three-dimensional velocity or motility coeffi  cient compared with control lymphocytes (P < 0.05).JEM VOL. 204, March 19, 2007  501
ARTICLE
In contrast, PI3Kγ−/− B cell motility was indistinguish-
able from control B cells. A thorough analysis did not reveal 
signifi  cant diff  erences in mean instantaneous three-dimen-
sional velocity, turning angles, or motility coeffi   cients (24.3 ± 
3.2 μm2/min for PI3Kγ−/− B cells vs. 21.9 ± 5.2 μm2/min for 
control cells; Fig. 2, A–D). Moreover, we did not detect an ad-
ditional eff  ect when the migratory behavior of DOCK2−/− × 
PI3Kγ−/− B cells was compared with DOCK2−/− single defi  -
cient B cells (Fig. 2, A–D). In summary, these observations 
support a central role for DOCK2 during interstitial B cell 
migration (Video S6, available at http://www.jem.org/cgi/
content/full/jem.20061780/DC1). The absence of PI3Kγ, 
on the other hand, did not aff  ect B cell motility within lym-
phoid tissue.
S1P-induced protein kinase B (PKB) activation, F-actin 
polymerization, and migration in the absence of DOCK2 
and PI3K
Effi   cient lymphocyte egress from PLNs depends on S1P1, a 
Gαi-coupled receptor expressed on naive lymphocytes (1, 24). 
The concomitant expression of CKR and S1P1 on the same 
cell type and the involvement of DOCK2 and PI3Kγ dur-
ing lymphocyte homing to PLNs and interstitial migration 
prompted us to investigate a role for these molecules in S1P-
induced signal transduction. In cell lines, S1P has been de-
scribed to induce PI3K, Rac, and ERK activation, as well 
as cell migration, among other downstream eff  ects (34–36). 
We fi rst evaluated PKB phosphorylation as an indirect mea-
sure for PI3K activity in control and genetically modifi  ed 
lymphocytes. As S1P1 surface levels are highly susceptible 
to down-regulation by S1P in the lymph and blood (37), 
we allowed lymphocytes to recover S1P1 expression after 
overnight (o.n.) incubation in fatty acid–free medium. 
Under these conditions, both control and genetically defi  -
cient lymphocytes exhibited comparable S1P1 surface levels 
(Fig. S2 A, available at http://www.jem.org/cgi/content/
full/jem.20061780/DC1). Upon stimulation with che-
mokines or S1P, phosphorylated PKB was readily detected 
in   control lymphocytes as well as in PI3Kγ−/− B cells. 
DOCK2−/− lymphocytes had reduced but detectable lev-
els of phosphorylated PKB after S1P stimulation (Fig. 3 A). 
In contrast, PKB did not undergo phosphorylation in 
PI3Kγ−/− T cells after chemokine or S1P addition (Fig. 3 A). 
These data suggest that S1P activates PKB in a PI3Kγ-
  dependent manner in T cells and via a diff  erent mechanism 
in B cells.
Figure 2.  Follicular B cell migration in the absence of DOCK2 
and PI3K𝗄. Control B cells were adoptively transferred with 
DOCK2−/−, PI3Kγ−/−, or DOCK2−/− × PI3Kγ−/− B cells, and their mi-
gratory behavior was analyzed inside B cell follicles using MP-IVM as 
in Fig. 1. (A) Representative three-dimensional tracks of control B cells 
(+/+; left column), DOCK2−/−, PI3Kγ−/−, or DOCK2−/− × PI3Kγ−/− 
B cells (−/−; right column) during 30-min observation periods. 
Each colored line represents a single B cell track. (B) Velocity pro-
files of control B cells (green bars) and DOCK2−/−, PI3Kγ−/−, or 
DOCK2−/− × PI3Kγ−/− B cells (red bars). Histograms show the relative 
frequency distribution of different populations compared with control 
B cells. (C) Turning angles of control B cells (+/+; top green panel) 
and DOCK2−/−, PI3Kγ−/−, or DOCK2−/− × PI3Kγ−/− mice B cells (−/−; 
bottom red panel). (D) Motility coeffi  cients of B cells in the presence or 
absence of DOCK2 and/or PI3Kγ. Each dot represents the motility co-
effi  cient of one experiment. Filled dots, control B cells; empty dots, 
genetically defi  cient B cells. The bars indicate mean values. The statis-
tical analysis is summarized in Table I.502  DOCK2-MEDIATED LYMPHOCYTE MOTILITY AND EGRESS | Nombela-Arrieta et al.
We next assessed Rac-mediated F-actin formation in ab-
sence of DOCK2 or PI3K. Control lymphocytes displayed a 
robust F-actin polymerization after S1P addition (Fig. 3 B), 
which was blocked by prior incubation with FTY720-P or 
pertussis toxin (Fig. S2 B and not depicted). Of note, the 
S1P1-specifi  c agonist SEW2871 also inhibited S1P-mediated 
F-actin formation as early as 15 min of preincubation (Fig. 
S2 B). We observed substantial F-actin polymerization in 
DOCK2−/− T but not B cells (Fig. 3 B). Under these con-
ditions, F-actin formation in DOCK2−/− T cells was only 
signifi  cantly lower at the earliest time point measured (52% 
reduction at 5 s after S1P addition; P < 0.05). When F-actin 
polymerization was examined using freshly isolated lympho-
cytes, however, DOCK2-defi  cient T cells did not respond to 
S1P (Fig. S2 C), despite comparable S1P1 mRNA levels as 
assessed by quantitative RT-PCR (not depicted).
The incomplete inhibition of F-actin formation in 
DOCK2-defi  cient T cells suggested the existence of alterna-
tive pathways. PI3K is known to mediate detectable F-actin 
formation in chemokine-stimulated T cells (31). When o.n. 
serum-starved control lymphocytes were pretreated with the 
PI3K inhibitor Wortmannin, S1P-induced actin polymeri-
zation at later time points (15–30 s) was signifi  cantly lower 
in T cells, although the initial F-actin polymerization peak 
was comparable to untreated cells (Fig. S2 C). S1P-triggered 
F-actin polymerization was also signifi   cantly reduced in 
PI3Kγ-defi  cient T cells at later time points (15–30 s; P < 
0.05), but not at the earliest time point measured (5 s; Fig. 
3 B). To assess the combined eff  ect of DOCK2 and PI3K 
defi  ciency downstream of S1P receptors, we blocked PI3K 
activity in DOCK2-defi  cient lymphocytes. Wortmannin 
treatment of DOCK2−/− T cells abolished residual S1P-
induced F-actin polymerization, suggesting that in lympho-
cytes, DOCK2 and PI3K independently lead to Rac activity 
important for actin cytoskeleton remodeling (Fig. S2 B). As 
predicted from this result, the combined lack of DOCK2 
and PI3Kγ in T cells completely eliminated F-actin forma-
tion in vitro (Fig. 3 B).
We performed in vitro chemotaxis assays to S1P to exam-
ine the functional consequences of reduced F-actin forma-
tion in the absence of DOCK2 and PI3Kγ. Control T cells 
exhibited a small but reproducible migration (Fig. 3 C) that 
could be blocked after pretreatment with FTY720-P (not de-
picted), in line with previous fi  ndings (38). Despite their re-
duced F-actin formation, PI3Kγ−/− T cells migrated to S1P 
comparably to control T cells, whereas only rare DOCK2−/− 
T cells accumulated in the lower chamber during the chemo-
taxis assay (Fig. 3 C). When compared with background mi-
gration, there was nonetheless a detectable migratory response 
in the absence of DOCK2, which was not present in T cells 
lacking both DOCK2 and PI3Kγ (Fig. 3 C). In B cells, no 
migration was observed in the absence of DOCK2, whereas 
PI3Kγ defi  ciency did not alter migration (Fig. 3 C and Fig. 
S2 D). Collectively, these in vitro data implicate DOCK2 
and PI3Kγ (in T cells) in the signaling cascade leading to 
F-actin formation and support a role for DOCK2 for effi   cient 
in vitro migration to S1P. PKB phosphorylation induced by 
S1P involves PI3Kγ in T cells and an alternative PI3K iso-
form in B cells.
Impaired lymphocyte egress from PLNs in the absence 
of DOCK2 but not PI3K𝗄
To determine whether DOCK2 defi  ciency aff  ected lympho-
cyte exit from PLNs in vivo, we performed egress experiments 
in which fluorescently labeled control and DOCK2−/− 
lymphocytes were adoptively transferred into wild-type re-
cipient mice and allowed to accumulate in PLNs for 4 or 20 h. 
Figure 3.  DOCK2 and PI3K𝗄 transmit signals downstream of S1P 
receptors. (A) Flow cytometric analysis of PKB phosphorylation 30 s after 
the addition of S1P (1 μM fi  nal concentration; red line) or 1 min after the 
addition of CXCL12 (100 nM fi  nal concentration; green line) in control, 
DOCK2−/−, or PI3Kγ−/− T and B cells using phosphorylated PKB-specifi  c 
antibody. The black line represents background staining in the absence of 
stimuli. (B) Flow cytometric analysis of F-actin polymerization after S1P 
addition (500 nM fi  nal concentration) in control, DOCK2−/−, PI3Kγ−/−, 
and DOCK2−/− × PI3Kγ−/− T and B cells. Data are presented as normal-
ized mean fl  uorescence intensity of FITC-Phalloidin binding, with the “0” 
time point = 100. Each value corresponds to the mean ± SD of at least 
three independent experiments. au, arbitrary units. (C) Chemotaxis of 
control, DOCK2−/−, PI3Kγ−/−, and DOCK2−/− × PI3Kγ−/− T and B cells to 
25 nM S1P for 4 h at 37°C. Signifi  cant migration to S1P over medium is 
marked with an asterisk (P < 0.05). Interconnected bars indicate signifi  -
cant difference (P < 0.05; ANOVA). Data represent mean ± SD of three 
independent experiments.JEM VOL. 204, March 19, 2007  503
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To block further homing, we then   administered i.v. 100 μg 
anti–L-selectin mAb (Mel-14), as described previously 
(19, 25, 33). Because DOCK2−/− T cells adhere well in HEV 
but accumulate more slowly in surrounding tissue (31, 39), 
mice were left for 2 h after mAb injection to allow adherent 
cells to either transmigrate into PLNs or to detach and reen-
ter the circulation. As lymphocytes gradually leave PLNs via 
eff  erent lymphatic vessels, and Mel-14 treatment prevents 
lymph node replenishment by blood-borne lymphocytes, 
these assays allow for the assessment of the egress effi   ciency 
for distinct cell populations. Mice were killed 2, 12, and 24 h 
after mAb treatment, and the total and relative numbers of 
control and DOCK2−/− T and B cells residing inside PLNs 
at each time point were determined using fl  ow cytometry to 
establish a retention ratio, defi  ned as the ratio of recovered 
gene-defi  cient over control lymphocytes per each time point, 
corrected for input. The gradual reduction of total cell num-
bers recovered from PLNs after Mel-14 treatment (45% at 12 h 
and 85% at 24 h after mAb treatment) confi  rmed eff  ective 
PLN homing inhibition.
As predicted, total cell numbers and the ratio of control 
versus DOCK2−/− lymphocytes recovered from PLNs indi-
cated more effi   cient homing of the former population when 
Mel-14 was injected 4 h after cell transfer (Fig. S3 A, available 
at http://www.jem.org/cgi/content/full/jem.20061780/DC1). 
Immunohistological analysis of PLN sections revealed that 
under these conditions, DOCK2−/− cells often localized in 
close vicinity to HEVs, whereas control lymphocytes ap-
peared more dispersed throughout the section (Fig. S3 C). At 
12 h after mAb treatment, the absolute number of control 
lymphocytes inside the node experienced a gradual decrease, 
whereas DOCK2−/− T and B cell numbers remained essen-
tially constant during this time window (Fig. S3 A). Their 
relative inability to leave lymphoid tissue compared with 
control cells was refl  ected by the twofold increase in the re-
tention ratio during this period. At 24 h after mAb treatment, 
DOCK2−/− lymphocytes outnumbered control cells inside 
PLNs (Fig. S3 B).
As the slower egress of DOCK2-defi  cient lymphocytes in 
the above experiments may at least in part be due to their 
perivascular accumulation, we performed experiments in 
which adoptively transferred cells were allowed to accumu-
late in PLNs for 20 h before Mel-14 was injected to block 
further homing. PLN cryosection analysis confi  rmed that 
  under these conditions, control and DOCK2-defi  cient lym-
phocytes colocalized in lymph node stroma (Fig. 4 D). At 2 h 
after mAb treatment, fl  ow cytometry analysis of recovered 
adoptively transferred cells showed reduced homing of 
DOCK2−/− lymphocytes in PLNs (Fig. 4 A). When follow-
ing cells for the next 24 h after transfer, DOCK2-defi  cient 
lymphocytes egressed at a slower rate from PLNs compared 
with control cells (Fig. 4, A and B). Although control lym-
phocytes had an average dwell time (determined as the time 
point where 50% of the initial population is found in PLNs) 
of  11 h, DOCK2-defi  cient lymphocytes had a twofold 
  increased dwell time of 24 h. The slower egress is refl  ected by 
the increasing retention ratio over time in the absence of 
DOCK2, aff  ecting both T and B cells (Fig. 4 C).
We performed immunohistology of PLNs to evaluate the 
distribution of adoptively transferred cells at 12 and 24 h after 
transfer. 12 h after Mel-14 treatment, 65% of control lym-
phocytes (of 748 total cells counted) were inside or <50 μm 
from lymphatic vessels, whereas only 39% of DOCK2−/− 
lymphocytes were near LYVE-1+ structures (639 total cells 
counted; Fig. 4 D). Comparable results were obtained at 24 h 
after adoptive transfer, although fewer cells were present 
in sections (not depicted). The reduced accumulation of 
DOCK2-defi  cient cells close to lymphatic structures sug-
gests that the absence of DOCK2 delays lymphocyte egress 
Figure 4.  DOCK2 defi  ciency delays lymphocyte egress from PLNs. 
(A) Absolute numbers of control and DOCK2−/− lymphocytes recovered 
from PLNs at the indicated times after Mel-14 treatment (20 h after 
adoptive transfer). Fluorescently labeled control and DOCK2−/− lym-
phocytes were adoptively transferred into recipient mice, and after 20 h, 
further homing was blocked by the injection of Mel-14 mAb. n = 4 mice 
per time point from two independent experiments. (B) Kinetic of control 
and DOCK2−/− lymphocyte egress expressed as percent of normalized 
initial population. Asterisks indicate signifi  cant difference compared with 
control lymphocytes (P < 0.05). (C) Retention ratio of adoptively trans-
ferred total lymphocytes (open bars), T cells (gray bars), and B cells (fi  lled 
bars) at the indicated times after Mel-14 treatment (20 h after adoptive 
transfer). Individual mice are represented by open circles, and bars cor-
respond to mean values. The relative frequency of DOCK2−/− T and B cells 
increases during Mel-14 treatment, indicating slower egress kinetics. 
One-way ANOVA was used to determine signifi  cance between different 
time points. Interconnected columns are signifi  cantly different (P < 0.05). 
(D) Cryosections of PLNs isolated 2 and 12 h after Mel-14 treatment (20 h 
after adoptive transfer) showing distribution of CMFDA-labeled DOCK2+/+ 
lymphocytes and CMTMR-labeled DOCK2−/− lymphocytes. HEVs are 
stained with anti-PNAd mAb MECA-79 in the top panel and lymphatic 
endothelium with LYVE-1 antibody in the bottom panel (blue). For clarity, 
a rectangular segment of each section has been magnifi  ed as indicated. 
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without completely abolishing it. Similarly, when we isolated 
thoracic duct lymph and PLNs from recipient mice 36 h after 
adoptive transfer, approximately two to three times fewer 
DOCK2−/− T cells compared with control T cells were 
found in lymph when normalized to the population recov-
ered from PLNs (not depicted).
Based on the decreased F-actin formation by PI3Kγ−/− 
T cells in vitro, we also wanted to address whether and to 
what extent PI3Kγ was implicated in lymphocyte dwell time 
under physiological conditions. To this end, we performed 
similar PLN egress experiments comparing control and 
PI3Kγ−/− lymphocytes. As reported (31, 32), we detected a 
small but reproducible reduction in PLN homing by PI3Kγ-
defi  cient lymphocytes as compared with coinjected wild-type 
cells (Fig. 5 A). Nonetheless, the rates of control and 
PI3Kγ−/− T and B cell egress were comparable throughout 
the entire observation period, as illustrated by a similar de-
crease in absolute cell numbers and similar retention ratios at 
all time points analyzed (Fig. 5, A and B). Interstitial distribu-
tion of transferred cells with respect to MECA-79+ or LYVE-1+ 
vessels was always comparable in control and PI3Kγ−/− lym-
phocytes at all time points analyzed (not depicted).
Finally, we adoptively transferred DOCK2 × PI3Kγ-
  defi  cient lymphocytes and performed egress assays to address 
whether residual egress observed in DOCK2-defi  cient lym-
phocytes depended on PI3K activity. Lack of PI3Kγ did not 
further delay egress of DOCK2-defi  cient lymphocytes, iden-
tifying the absence of DOCK2 as the major cause for de-
creased lymphocyte egress (Fig. 5 C). Similar results were 
obtained when DOCK2−/− lymphocytes were pretreated 
with Wortmannin before adoptive transfer (not depicted). 
Thus, DOCK2 but not PI3Kγ defi  ciency increases lymph 
node dwell time in vivo by slowing lymphocyte egress 
from PLNs.
T cell motility in PLN medulla is reduced in the absence 
of DOCK2
Despite the reduced responsiveness of DOCK2−/− lympho-
cytes to S1P in vitro, it remained unclear whether the increased 
lymph node dwell time of DOCK2-defi  cient T cells was due 
to low sensitivity to S1P-mediated egress signals in addition to 
the overall reduced accumulation in medullary cords. We 
therefore directly investigated the migratory behavior of con-
trol and DOCK2-defi  cient T cells in the medullar region of 
PLNs, where S1P-dependent lymphocyte egress takes place 
(21, 24, 37). Explanted PLNs were immobilized with the hilus 
facing the objective, whereas eff  erent lymphatic vessels were 
identifi  ed by labeling with fl  uorescent wheat germ agglutinin 
(WGA), as described previously (40). We analyzed cell motil-
ity of adoptively transferred T cells 15–65 μm below the cap-
sule in close proximity to WGA-labeled vessels during 30-min 
observation periods.
Control T cells exhibited continuous motility with an 
average speed of 8.8 ± 2.1 μm/min (Fig. 6, B and C, and 
Video S7, which is available at http://www.jem.org/cgi/
content/full/jem.20061780/DC1). These cells occasionally 
entered and left the lymphatic vascular lumen (Fig. 6 A), 
as verifi  ed by careful assessment of volume-rendered sections 
(not depicted). In contrast, much fewer DOCK2-  defi  cient 
T cells were observed in the medullar region, in line with our 
immunohistological data (Fig. 4 D). DOCK2−/− T cells in 
medullary cords were even less motile as in the paracortex 
  (average velocity, 3.7 ± 1.6 μm/min; P < 0.01 compared 
with control T cells) and remained stationary during the ob-
servation period (Fig. 6, A–C, and Video S8, which is available 
at http://www.jem.org/cgi/content/full/jem.20061780/DC1). 
The diff  erent motility is refl  ected in shortened average track 
lengths in the absence of DOCK2 (Fig. 6 B). DOCK2 is 
therefore required for effi   cient motility near eff  erent lym-
phatic vessels in the medulla.
DISCUSSION
Observations using MP-IVM have provided important 
  insights into the remarkable interstitial motility of lympho-
cytes, which migrate hundreds of micrometers every day 
during their long life span (10, 12–15, 28). The data pre-
sented here provide novel information about intracellular 
signaling factors required for effi   cient interstitial T and B cell 
motility within and egress from PLNs, and uncover a central 
role for the lymphocyte-expressed Rac guanine exchange 
factor DOCK2. First, we demonstrate that DOCK2 is 
needed for eff  ective T and B cell motility inside paracortex 
and follicles, whereas PI3Kγ helps maintain temporal direc-
tionality during interstitial migration of T cells. Second, our 
fi  ndings show roles for both DOCK2 and PI3K during 
S1P-triggered signaling, but only DOCK2 is important for 
effi   cient egress from PLNs. In combination with previous 
Figure 5.  PI3K𝗄 defi  ciency does not affect lymphocyte egress 
from PLNs. (A) Total numbers of PI3Kγ+/+ and PI3Kγ−/− cells present in 
PLNs at 2, 12, and 24 h after Mel-14 mAb treatment (4 h after adoptive 
transfer). Data represent mean ± SD from at least three mice from two 
independent experiments. (B) Retention ratio of PI3Kγ+/+ and PI3Kγ−/− 
T and B cells at 2, 12, and 24 h after cell transfer. Each circle represents 
individual mice, and bars depict mean values. Shown are transferred total 
lymphocytes (open bars), T cells (gray bars), and B cells (fi  lled bars) at the 
indicated times after Mel-14 mAb treatment. No signifi  cant difference in 
ratio became apparent. (C) Retention ratio of DOCK2−/− and DOCK2−/− × 
PI3Kγ−/− T and B cells. 20 h after cell transfer, further homing was 
blocked by Mel-14 mAb administration, and mice were killed at 2 and 
20 h later. Each circle represents individual mice, and bars depict mean 
  values. Shown are transferred total lymphocytes (open bars), T cells (gray 
bars), and B cells (fi  lled bars) at the indicated times after Mel-14 mAb 
treatment. Data are from two independent experiments with four mice 
per time point. No signifi  cant difference in ratio became apparent.JEM VOL. 204, March 19, 2007  505
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fi  ndings regarding chemokine-induced migration (30, 31), 
the results presented here suggest a dominant role for 
DOCK2 over PI3K in intracellular signaling pathways that 
control central aspects of lymphocyte recirculation: homing, 
interstitial migration, and egress.
DOCK2 and PI3Kγ have well-described roles in CKR 
signaling in lymphocytes. Both contribute, in a largely inde-
pendent manner, to migratory responses of T lymphocytes 
toward chemokine gradients in vitro (30–32, 41). The 
strongly reduced lymphocyte motility in the absence of 
DOCK2 underlines its nonredundant role for effi   cient cell 
movement induced by tissue-derived promigratory factors 
present in lymph stroma. Migration requires cell polarization 
and translocation of polarized cells (42). In vitro, DOCK2−/− 
lymphocytes show defective polarization in response to a 
uniform chemokine gradient (31). It is currently unclear 
whether within interstitial tissue DOCK2−/− cells fail to po-
larize in response to tissue-derived promigratory factors and/
or whether DOCK2 is additionally required for effi   cient 
translocation. The presence of rare fast-moving DOCK2−/− 
T cells may indicate that even in the absence of DOCK2, a 
threshold polarization state can be achieved that allows 
for effi     cient translocation. Although the large majority of 
adoptively transferred cells found in PLNs correspond to 
phenotypically naive lymphocytes, we cannot exclude that 
occasional fast T cells represent subsets of central memory cells 
in which migration is mediated by DOCK2-independent 
pathways. The minor defect of PI3Kγ-defi  cient T cells in 
maintaining temporal directionality is reminiscent of the 
aberrant PI3Kγ−/− neutrophil migration toward increasing 
concentrations of chemoattractant. Similar to interstitially 
migrating T cells, PI3Kγ−/− neutrophils display only mildly 
decreased translocation speeds but are unable to form a 
persistent leading edge due to ineff   ective recruitment of 
pleckstrin homology domain–containing intracellular factors 
stabilizing the leading edge (43, 44).
The precise tissue-derived factors responsible for random 
lymphocyte motility within lymphoid tissue remain  un-
known. Numerous genetically modifi  ed mouse strains and 
the conspicuous expression pattern in locally distinct micro-
environments point to a central role for chemokines in the 
overall organization of SLOs (1–3). Fibroblastic reticular cells 
and follicular dendritic cells form three-dimensional net-
works in T and B cell areas, respectively, and are the major 
chemokine-producing cells in lymphoid tissue (6, 45), allow-
ing to speculate that chemokines on the surface of stromal 
cell networks contribute to continuous lymphocyte motility 
(16). In vitro, lymphocytes are generally nonmotile (12), al-
though recent reports describe the induction of detectable 
random lymphocyte migration by homeostatic chemokines 
(17, 18). Furthermore, directed migration of activated B cells 
toward the T–B cell border area was found to depend on 
CCR7 and a CCL21 gradient (46). Similarly, the CKR 
CCR5 expressed on CD8 cells under proinfl  ammatory con-
ditions allows these cells to approach APC-CD4 clusters 
more effi     ciently (47), although factors promoting random 
motility were not investigated in these studies. To date, there 
is nonetheless no direct evidence that homeostatic chemo-
kines such as CCL19 or CCL21 are responsible for interstitial 
random motility. The major factor compounding a useful in 
situ analysis of the role of CKR during interstitial migration 
lies in their central role during recruitment of blood-borne 
lymphocytes into SLOs. For example, genetic ablation of 
CCR7 or its ligands results in loss of recruitment of naive T 
lymphocytes into PLNs, making it diffi   cult to analyze their 
role in interstitial migration (8, 9). Because chemokines pre-
sent in lymph nodes induce internalization of their cognate 
receptors in vitro (48), an unsolved question is how these fac-
tors can promote continuous migration observed in vivo.
Besides chemokines, other tissue-derived factors may 
contribute to interstitial cell motility. Dendritic cells secrete 
the lipid mediator thromboxane A2, which enhances T cell 
chemokinesis in vitro by binding TP, a Gαi-linked GPCR 
(49). Of note, TP levels are higher on T cells than on B cells, 
correlating with increased motility of the former population (49). 
Figure 6.  Medullar T cell migration in the absence of DOCK2. 
(A) Image sequence of control and DOCK2-defi  cient T cells proximal to 
efferent WGA+ lymphatic vessels (green, outline labeled white for greater 
clarity). A control T cell entering WGA-labeled lymphatic vessel is shown, 
whereas DOCK2-defi  cient T cells remained stationary during the observa-
tion period. The asterisks mark the initial tracking spot. Time is in minutes 
and seconds. Bar, 10 μm. (B) Representative three-dimensional tracks of 
control and DOCK2−/− T cells tracked for 30 min. 10 tracks are shown for 
each genotype. Scale is in micrometers. (C) Velocity profi  le of control and 
DOCK2-defi  cient medullar T cells. 886 control T cell and 138 DOCK2−/− 
T cell tracks were analyzed from four to fi  ve independent videos.506  DOCK2-MEDIATED LYMPHOCYTE MOTILITY AND EGRESS | Nombela-Arrieta et al.
Finally, DOCK2 also acts downstream of the TCR (50), 
raising the possibility that non-GPCR surface receptors 
may participate in T cell interstitial motility. The identifi  ca-
tion of DOCK2 as a key player of continuous lymphocyte 
movement does therefore not further clarify the role of che-
mokines or additional tissue-derived factors in this process. 
However, recent data identifi  ed several molecules involved 
in GPCR signaling as important factors in promoting ran-
dom B cell migration inside SLOs, as B cells lacking Gαi2 or 
RGS1 have strongly impaired or increased interstitial motil-
ity, respectively (19). The data presented here are in line 
with these observations, as DOCK2 and PI3Kγ act down-
stream of CKR, and DOCK2−/− mice show evidence of 
markedly hypotrophic SLOs, with disturbed T and B cell 
compartmentalization (30). The close correlation between 
in vitro responsiveness to chemokines and interstitial motility 
in the absence of Gα12, RGS1, DOCK2, and PI3Kγ is 
noteworthy and suggests a strong overlap between CKR-
mediated intracellular signaling pathways with those mediat-
ing random motility.
Absence of DOCK2 aff  ects overall displacement of T and 
B cells, severely impairing the capacity of lymphocytes to 
screen extensive areas within their respective microenvi-
ronments. Recent in vitro data suggest that random motility 
increases effi   cient lymphocyte activation by facilitating en-
counters with CD3/28-coated beads or APCs (17, 18). An 
interesting question is therefore how tissue motility correlates 
with immune response initiation in vivo. However, studying 
the impact of reduced motility on immune response initia-
tion in the absence of DOCK2 is hampered by the fact that it 
also acts downstream of TCR, resulting in reduced prolifera-
tion in vitro in response to irradiated splenocytes as APCs 
(50). It is thus diffi   cult to directly assess the role of APC–T 
cell encounter effi   ciency for early onset or magnitude of 
  immune responses in this model.
Lymphocyte egress from PLNs requires signals triggered 
by S1P, which binds to fi  ve widely expressed GPCRs, S1P1–5 
(1, 20, 34, 35). The fi  rst indication of participation of S1P re-
ceptors during lymphocyte recirculation came from studies 
using FTY720, an immunosuppressive agent sharing struc-
tural homology with S1P (21). Orally administered FTY720 
becomes rapidly phosphorylated by S1P kinase 2 (51, 52) 
and, after agonistic binding to S1P receptors, induces a 
continuous loss of S1P1 surface expression on lymphocytes 
through receptor internalization and degradation (23, 37). It 
is currently controversial whether pharmacological com-
pounds blocking or stimulating S1P1 signaling act mainly on 
lymphocytes or lymphatic endothelial cells, as S1P1 expressed 
on lymphatic endothelium may participate in lymphocyte 
exit control through regulation of endothelial barrier prop-
erties (40, 53, 54). The interpretation of pharmacological 
studies is complicated by our observation that SEW2871, 
which acts as an S1P1-specifi  c agonist in certain cell lines 
(55), behaves as a functional antagonist in lymphocytes, simi-
lar to FTY720-P (Fig. S2 B). Pharmacological agonists and 
antagonists need thus to be carefully analyzed for their eff  ects 
on primary cells to obtain a clearer picture on their eff  ect on 
potential target cell populations.
Several observations clearly indicate that lymphocyte-
  expressed S1P1 is absolutely required for physiological lym-
phocyte exit from lymphoid tissues. S1P1-defi  cient mature 
thymocytes are retained in thymus and, upon adoptive trans-
fer, in PLNs (24, 25, 56). In addition, a series of elegant ex-
periments demonstrated that CD69 expressed on recently 
activated lymphocytes is critically involved in down-regulation 
of lymphocyte-expressed S1P1, resulting in effi   cient trapping 
of antigen-specifi   c lymphocytes in infl   amed PLNs (57). 
CD69 levels do not diff  er between control and DOCK2-
  defi  cient lymphocytes (not depicted), excluding a role for this 
pathway in controlling the dwell time of DOCK2-defi  cient 
cells. As lymphocytes are able to migrate toward S1P in vitro 
and S1P1 surface levels gradually increase with lymphocyte 
dwell time in PLNs (24, 37, 38), the simplest working hy-
pothesis is that egress is a chemotactic response to S1P. This 
hypothesis is consistent with the recent observation that lym-
phocyte movement from medullar cords into lymph and 
blood requires S1P lyase. S1P lyase activity may create an 
S1P concentration gradient between lymphatic fl  uid and 
intranodal stroma, thus establishing a guidance cue for 
egressing lymphocytes (58). Of note, FTY720 also inhibits 
S1P lyase, which may further contribute to lymphocyte 
  sequestration (59).
In line with decreased migration to S1P in vitro, multi-
photon imaging showed a strongly reduced motility of me-
dullar DOCK2-defi  cient T cells, which probably refl  ects a 
defect in the transmission of S1P-derived promigratory egress 
signals. This is supported by the observation that migration of 
lymphocytes in medulla is controlled by diff  erent molecular 
cues as paracortical migration refl  ected by slower migratory 
speed and increased susceptibility to pharmacological com-
pounds altering S1P signaling (40, 54). It has to be cautioned, 
however, that our use of explanted lymph nodes results in an 
interruption of lymphatic fl  ow, which may alter the physio-
logical migratory behavior, especially concerning diapedesis 
into lymphatic vessels.
Our data show that in fatty acid–starved T cells stimu-
lated by S1P, DOCK2 mediates early F-actin polymeriza-
tion, whereas PI3K activity appears more important for a 
second, delayed wave of F-actin formation. It is interesting 
to note that the fi  rst wave of F-actin formation correlates 
with effi   cient migration to S1P in vitro and egress in vivo, 
whereas the lack of PI3K-dependent, slower F-actin forma-
tion does not strongly reduce lymphocyte migration or 
egress. The relation of two separate F-actin formation path-
ways and their physiological function is at present uncertain. 
T cells express mainly two of the fi  ve known S1P receptors, 
S1P1 and S1P4, although only S1P1 appears to be necessary 
for effi   cient egress (1). It is possible that S1P1 and S1P4 show 
preferential intracellular coupling to DOCK2 and PI3Kγ, 
respectively, with DOCK2-Rac activity mediating a more 
robust migration. However, this needs to be experimentally 
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DOCK2- but not PI3Kγ-defi  cient T cells had a strongly re-
duced S1P-induced F-actin formation, which may indicate 
that serum starvation does not represent the appropriate 
physiological context for measuring S1P responsiveness. 
  Finally, it is important to note that DOCK2- and PI3K-
  independent pathways controlling lymphocyte exit clearly 
exist, which merits further investigation.
An interesting question is how lymphocytes compute 
various extracellular stimuli resulting in a given physiological 
outcome such as random interstitial motility versus egress. 
Our data suggest that both CKR and S1P1 share important 
molecular players mediating migration, which could point to 
a central role for surface receptor expression levels, as has 
been suggested (37). However, in contrast to CKR and S1P1 
expressed in cell lines (36, 55), S1P did not induce effi   cient 
ERK phosphorylation in primary lymphocytes, indicating 
that S1P1 and CKR share some but not all signal transduction 
pathways (Fig. S2 E). Within lymphoid tissue, chemokines 
are abundant while S1P levels are low (58, 60), and in in vitro 
assays, lymphocytes respond much more avidly to chemo-
kines than to S1P. It is thus likely that in addition to regulat-
ing S1P1 surface expression, other mechanisms are necessary 
for successful lymphocyte egress, such as a state of temporary 
unresponsiveness to tissue-derived factors, including chemo-
kines. High levels of S1P, as may be present in close proximity 
to eff  erent lymphatic vessels, were found to suppress chemo-
tactic responses of CD4 cells to homeostatic chemokines 
(61), providing a working model to address the balance of 
random interstitial motility and egress.
In summary, we show that within PLNs, T and B cells 
require DOCK2 for extensive screening of their respective 
microenvironments, while PI3Kγ helps maintaining tempo-
ral directionality during interstitial T cell migration. Further-
more, our data show an important role for DOCK2, and to a 
minor extent PI3K activity, for S1P-induced F-actin poly-
merization and migration. Reduced S1P responsiveness in 
the absence of DOCK2 likely contributes to the increased 
dwell time of DOCK2-defi  cient lymphocytes within PLNs. 
The simultaneous targeting of homing (30, 31), interstitial 
migration, and egress is probable to induce a permanent 
immuno  compromised state in mice lacking DOCK2. In 
combination with impaired TCR signaling, it is perhaps not 
surprising that deletion of DOCK2 enables long-term sur-
vival in a murine model of cardiac allograft transplant (62). 
We therefore consider DOCK2 an interesting therapeutic 
target to simultaneously alter various processes controlling 
lymphocyte traffi   cking and function while not completely 
shutting down the immune system.
MATERIALS AND METHODS
Reagents and mice. AMCA-conjugated anti–rat IgM and Alexa350-con-
jugated anti–rabbit Ig were from Jackson ImmunoResearch Laboratories. 
Anti–LYVE-1 was purchased from RELIATech. Anti–mouse S1P1 poly-
clonal rabbit Ig directed against the N and C terminus was provided by 
S. Mandala and E.J. Quackenbush (Merck Research Laboratories, Rahway, 
NJ). All other antibodies were from BD Biosciences or affi   nity purifi  ed from 
hybridoma supernatant (Mel-14; Nanotools). S1P and human collagen type IV 
were purchased from Sigma-Aldrich. CMTMR (CellTracker orange), 
CMFDA (CellTracker green), and CFSE were from Invitrogen. SEW2871 
was from Calbiochem.
6–12-wk-old control, DOCK2−/−, PI3Kγ−/−, and DOCK2−/−  × 
PI3Kγ−/− mice in a C57BL/6 background were used for all experiments. 
CD45.1+ C57BL/6 used in some reconstitution experiments were from 
The Jackson Laboratory. All experiments were performed in accordance 
with National Institutes of Health (NIH) guidelines and approved by the 
Committees on Animal Care and Use of Harvard Medical School, the CBR 
Institute for Biomedical Research, and the Kanton of Bern.
MP-IVM of popliteal PLNs. Single cell suspensions were obtained from 
the PLNs, mesenteric lymph nodes, and spleens of control and genetically 
defi  cient mice. Alternatively, in some experiments (control and PI3Kγ−/− 
T cells, and control, DOCK2−/−, PI3Kγ−/−, and DOCK2−/− × PI3Kγ−/− 
B cells), cells were isolated from irradiated CD45.1+ mice reconstituted with 
CD45.2+ bone marrow cells from control, DOCK2−/−, PI3Kγ−/−, and 
DOCK2−/− × PI3Kγ−/− mice, respectively. When required, endogenous 
CD45.1+ cells were eliminated by negative selection with anti-CD45.1–
coated magnetic beads (Miltenyi Biotec). In all experiments, T and B cell 
isolation was performed by negative immunomagnetic cell sorting (Miltenyi 
Biotec) with purity yields of >95% for T cells and >90% for B cells. Purifi  ed 
control, DOCK2−/−, PI3Kγ−/−, or DOCK2−/− × PI3Kγ−/− T or B cells 
were fl  uorescently labeled with 5 μM CFSE or 10 μM CMTMR for 15 min 
at 37°C, washed, and injected i.v. into sex-matched 6-wk-old C57BL/6 re-
cipient mice. Numbers of transferred lymphocytes (2–10 × 106 cells) were 
calculated according to the homing ability of each subset to allow suffi   cient 
accumulation of cells inside the node for visualization. When we checked 
the phenotype of control and DOCK2-defi  cient adoptively transferred T or 
B lymphocytes by fl  ow cytometry, we found that >99% of transferred cells 
in PLNs were either Thy1.2+ or B220+, with >70% corresponding to bona 
fi  de naive lymphocytes (Fig. S1). 15–22 h after transfer, recipient mice were 
anesthetized and the right popliteal lymph node was surgically exposed, as 
described previously (33). Multiphoton imaging was performed with an 
Olympus BX50WI fl  uorescence microscope equipped with a 20× objective 
and a Bio-Rad Radiance 2000 MP Confocal/Multiphoton microscopy sys-
tem, controlled by Lasersharp software (Bio-Rad Laboratories). For multi-
photon excitation and second harmonic generation, a Ti:sapphire laser with 
a 10-W MilleniaXs pump laser (Tsunami; Spectra-Physics) was tuned to 
800 nm. For four-dimensional analysis of cell migration, stacks of 16 square 
x-y sections were acquired every 15 s during 30 min with electronic zooming 
up to 6× to provide image volumes of 60 μm in depth. Emitted light and 
second harmonic signals were detected through 400/40-nm, 525/50-nm, and 
620/100-nm bandpass fi  lters with nondescanned detectors to generate three-
color images. Sequences of image stacks were transformed into volume-
rendered four-dimensional movies using Volocity software (Improvision), 
which was also used for semi-automated tracking of cell motility in three 
dimensions. From x, y, and z coordinates of cell centroids, parameters of 
cellular motility were calculated as described previously (33). In brief, the 
instantaneous three-dimensional velocity is the cellular velocity between 
two time points, whereas the turning angle describes the angle between the 
two velocity vectors before and after a measurement time point (12). Both 
parameters are determined independently for each cell track.
S1P-induced PKB and ERK phosphorylation, F-actin polymeriza-
tion, and migration. Lymphocyte isolation and functional experiments 
were performed in RPMI supplemented with 1 mg/ml of fatty acid–free 
BSA, L-Gln, NaPyruvate, β-mercaptoethanol, and PenStrep (RPMI-BSA). 
After o.n. incubation in RPMI-BSA at 37°C, 7% CO2, lymphocytes were 
stimulated with 500 nM S1P or 100 nM CXCL12, permeabilized, and incu-
bated with anti-phosphoPKB or anti-phosphoErk (Cell Signaling Labora-
tories). As secondary antibodies, we used biotinylated anti–rabbit IgG 
(Jackson ImmunoResearch Laboratories), followed by APC-conjugated 
streptavidin (BD Biosciences). Comparable results were obtained using 
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Actin polymerization assays were performed as described previously 
(31). In brief, single cell suspensions of total lymphocytes (107 cells/ml) were 
stimulated with 500 nM S1P, and aliquots were taken at indicated time 
points, followed by immediate fi  xation in 4% paraformaldehyde for 15 min. 
Cells were washed with PBS and stained for Thy1.2+ and B220+ cells, per-
meabilized, labeled with FITC-Phalloidin (Invitrogen), and analyzed by 
fl  ow cytometry using CELLQuest software (Becton Dickinson). In some 
experiments, lymphocytes were treated with 0.1 μg/ml pertussis toxin 
(Sigma-Aldrich), 0.5 μM Wortmannin (Calbiochem), 5 μM SEW2871, or 
0.5 μM FTY720 or FTY720-P (provided by V. Brinkmann, Novartis, 
Basel, Switzerland, and S. Mandala and E.J. Quackenbush, respectively) for 
15 min or 2 h at 37°C, 7% CO2, before S1P stimulation.
Chemotaxis assays were performed using Transwell chambers (5-μm 
pore size; CoStar). Filters were coated o.n. at 4°C with a 10 μg/ml solution 
of human collagen type IV, washed twice with 500 μl PBS, and dried 
  before use. Uncoated fi  lter inserts were used with comparable results. 106 
lymphocytes in 100 μl RPMI-BSA was placed in the top chamber and al-
lowed to migrate to 25 nM S1P for 4 h at 37°C, 7% CO2. This concentra-
tion was found to be optimal for both control and DOCK2−/− lymphocytes 
over a range from 10 nM to 1 μM S1P (unpublished data). The percentage 
of total migrated cells was determined by fl  ow cytometry comparing with a 
precalibrated bead standard (Sigma-Aldrich). After migration, input and 
migrated populations were labeled for T and B cells to calculate percentages 
of subset migration.
Determination of S1P1 mRNA levels and surface expression. Total 
RNA was isolated from freshly isolated CD4+ T cells according to the man-
ufacturer’s instructions (QIAGEN). Quantitative RT-PCR was performed 
using the universal probe library system (Roche Applied Science). For S1P1 
surface labeling, lymphocytes were incubated o.n. in RPMI-BSA and 
labeled with anti–mouse N-terminal S1P1-specifi  c rabbit Ig, followed by 
biotinylated anti–rabbit Ig and streptavidin-APC. As controls, we used 
C-terminal S1P1 or S1P4-specifi  c rabbit Ig and FTY720-P pretreatment.
Lymph node egress assays. Total lymphocytes were isolated from the 
spleens and PLNs of control and genetically defi  cient mice and fl  uorescently 
labeled using 0.3 μM CMFDA or 1.5 μM CMTMR for 45 min, 5% CO2, 
37°C in RPMI supplemented with 10% FCS, L-Gln, NaPyruvate, β-mer-
captoethanol, and PenStrep (CM-R). Depending on the homing ability of 
diff  erent subsets, 2–4 × 107 cells of each cell population were mixed in 200 
μl CM-R and injected i.v into age- and sex-matched C57BL/6 recipient 
mice. 4 or 20 h after lymphocyte transfer, mice received i.v. injections of 
Mel-14 (100 μg/mouse) to prevent further homing. Mice were killed 2, 12, 
and 24 h after mAb injection for assessment of the rate of egress of injected 
lymphocytes from PLNs. SLOs and blood were collected, labeled with anti-
Thy1.2 and anti-B220, and the numbers of adoptively transferred T and B 
cells were determined using fl  ow cytometry. For each organ, absolute num-
bers of each lymphocyte subset were calculated by using a precalibrated bead 
standard. A lymph node retention ratio was determined for each time point 
as the ratio of (percent recovered gene-defi  cient lymphocytes/percent re-
covered control lymphocytes) × correction factor for the input population 
ratio, as described previously (31). One lymph node from each mouse was 
snap frozen for immunohistological analysis.
Immunohistology. 8-μm sections of frozen PLNs were fi  xed for 10 min 
in 2% paraformaldehyde, washed in PBS, blocked with FCS, and stained 
with anti-PNAd (MECA-79) or anti–LYVE-1 antibody. AMCA-conjugated 
anti–rat IgM or Alexa350-conjugated anti–rabbit Ig were used as secondary 
antibody. Preparations were observed using a fl  uorescence  microscope 
(Nikon). For determination of cell distribution, adoptively transferred lympho-
cytes were considered close to LYVE-1+ structures at a distance of <50 μm.
Multiphoton imaging of PLN medulla. CMTMR-labeled control or 
DOCK2−/− T cells (2–10 × 106 cells/mouse) were adoptively transferred 
into C57BL/6 mice 16–24 h before isolation of PLNs (axillary, brachial, and 
inguinal). Explanted PLNs were labeled for 5 h with AlexaFluor488-conju-
gated WGA on ice as described previously (40). Labeled PLNs were care-
fully immobilized on a glass slide with the hilus facing up and imaged using 
a Trimscope MP system (LaVision) equipped with a MaiTai HP Ti:Sa laser 
(Spectraphysics). During image acquisition, PLNs were kept at 35–37°C and 
continuously superfused with oxygenated (95% O2, 5% CO2) bicarbonate 
buff  ered solution (130 mM NaCl, 2.5 mM KCl, 1.3 mM NaH2PO4, 26 mM 
NaHCO3, 1 mM MgCl2, 2 mM CaCl2, and 10 mM glucose, pH 7.4, when 
equilibrated with a mixture of 95% O2 and 5% CO2). Image stacks (200 × 
200 × 40 μm) between 10 and 65 μm below the lymph node surface were 
taken every 15 s during 30 min with a z-step size of 4 μm, using 840 nm 
  excitation wave length. Fluorescent and second harmonic generation signals 
were collected using 455/50 and 525/50 bandpass fi  lters or 560LP fi  lters and 
analyzed using Volocity software. The average track velocity was calculated 
as total track length over tracking time.
Statistical analysis. The Student’s t test or one-way analysis of variance 
(ANOVA) was used for statistical analysis (Prism or InStat; GraphPad Soft-
ware). Signifi  cance was set at P < 0.05.
Online supplemental material. Fig. S1 shows a fl  ow cytometric analysis 
of the phenotype of adoptively transferred wild-type and DOCK2−/− 
T cells. Fig. S2 shows S1P1 surface expression levels of control and gene-
defi  cient lymphocytes, as well as S1P-induced F-actin formation, B cell 
migration, and ERK phosphorylation. Fig. S3 depicts PLN egress of con-
trol and DOCK2−/− lymphocytes after an initial 4-h homing period. 
Supplemental videos show interstitial motility of paracortical control and 
DOCK2−/− T cells (Videos S1 and S2), control and PI3Kγ−/− T cells 
(Video S3), control and DOCK2−/− × PI3Kγ−/− T cells (Videos S4 and 
S5), and follicular control and DOCK2−/− B cells (Video S6). Videos S7 
and S8 depict migration of medullar control and DOCK2−/− T cells, 
  respectively. The online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20061780/DC1.
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